retatrutide triple agonist obesity trial A new clinical from Eli Lilly and Company suggests its experimental hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes retatrutide phase 2 trial obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8


























